| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Active Ice Inc is a Norman, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
T.J. Samson Community Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Glasgow, KY. To find more information about T.J. Samson Community Hospital, please visit www.tjsamson.org
Abbiotec is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Weavr Health develops easy-to-use, reliable blood collection devices designed to ensure anyone, anywhere can access the best health and wellness care. Our mission is to create devices that connect people, and their providers, to better health.